- 专利标题: OPHTHALMIC COMPOSITION
-
申请号: US18055945申请日: 2022-11-16
-
公开(公告)号: US20230091109A1公开(公告)日: 2023-03-23
- 发明人: Gregory I. OSTROW , Kenneth J. WIDDER , David S. BAKER
- 申请人: Sydnexis, Inc.
- 申请人地址: US CA Del Mar
- 专利权人: Sydnexis, Inc.
- 当前专利权人: Sydnexis, Inc.
- 当前专利权人地址: US CA Del Mar
- 主分类号: A61K31/46
- IPC分类号: A61K31/46 ; A61K9/00 ; A61K47/02
摘要:
Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, Wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.
公开/授权文献
- US11896588B2 Ophthalmic composition 公开/授权日:2024-02-13
信息查询